Other pathways that have been implicated in AD are PPAR signaling pathway, regulation of actin cytoskeleton, Non-alcoholic fatty liver disease (NAFLD), and several signaling pathways. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.